Sort
261,768 grants matching “gene therapy”
Semantic LAMHDI: Linking diseases to model organism resources
$1,276,941Melissa A Haendel · Oregon Health & Science University · R24 · FY2015 · OD
Studies of Receptor Interactions and Effects of Alarmins
$1,276,907Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Multi-scale modeling of inherited pediatric cardiomyopathies
$1,276,811Kevin Kit Parker · Harvard University · UG3 · FY2018 · HL
Psoriasis Center of Research Translation
$1,276,741Kevin D Cooper · Case Western Reserve University · P50 · FY2017 · AR
Systems Biology Analysis of Influenza A Virus and Ebola Virus
$1,276,716Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2014 · AI
Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease
$1,276,596Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2022 · AG
Development of a novel disease modifying oral therapy for pulmonary arterial hypertension.
$1,276,514Jaipal Singh · Vasculonics, Llc · R44 · FY2025 · HL
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,276,503Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2023 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,276,483Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Immersive Simulation Program
$1,276,343Susan Persky · National Human Genome Research Institute · ZID · FY2023 · HG
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$1,276,309Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
$1,275,931Adel K. El-Naggar · University Of Tx Md Anderson Can Ctr · U01 · FY2012 · DE
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
$1,275,792Douglas A Marchuk · Duke University · P01 · FY2017 · NS
Molecular Mechanisms regulating membrane trafficking in salivary glands
$1,275,628Roberto Weigert · Dental & Craniofacial Research · Z01 · FY2007 · DE
Stem Cell Therapies for Primary Immune Deficiency
$1,275,602Gay Miriam Crooks · University Of California Los Angeles · P01 · FY2009 · AI
Multi-scale modeling of inherited pediatric cardiomyopathies
$1,275,414Kevin Kit Parker · Harvard University · UH3 · FY2019 · HL
BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL
$1,275,301University Of Minnesota Twin Cities · P01 · FY2000 · CA
Models of Human Immunodeficiencies
$1,274,973Beth Israel Deaconess Medical Center · P01 · FY2004 · AI
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,274,922Claire F Verschraegen · Ohio State University · UG1 · FY2024 · CA
Understanding the overlap of chromatin alteration in HIV-1 and drug abuse
$1,274,854Zachary Alan Klase · University Of The Sciences Philadelphia · DP2 · FY2017 · DA
Enhancer Therapy
$1,274,602Christopher K Glass · University Of California, San Diego · R01 · FY2014 · CA
Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
$1,274,593Tony Eissa · Baylor College Of Medicine · UH2 · FY2013 · TR
Editing Alveolar Progenitor Cells for Correction of Monogenic Disease
$1,274,477Jeffrey A Whitsett · Cincinnati Childrens Hosp Med Ctr · U01 · FY2019 · HL
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$1,274,401Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2021 · NR
Biomechanics and Inflammation in Osteoarthritis
$1,274,299Farshid Guilak · Duke University · P01 · FY2007 · AR